razoxane has been researched along with methotrexate in 16 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 10 (62.50) | 18.7374 |
1990's | 2 (12.50) | 18.2507 |
2000's | 2 (12.50) | 29.6817 |
2010's | 2 (12.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Hellmann, K; Hill, BT | 1 |
Grieder, A; Maurer, R; Stähelin, H | 1 |
Dulbecco, R; Rubens, RD; Vaughan-Smith, S | 1 |
Bale, G; Chesney, TM; Noah, PW; Rosenberg, EW; Skinner, RB; Xu, B | 1 |
Dorr, RT | 1 |
Griffiths, WA; Levene, GM; Steinman, HK | 1 |
Bahendeka, S; Katongole-Mbidde, E; Kyalwazi, SK; Mugerwa, J; Olweny, CL; Otim, D | 1 |
Aresca, S; Fuente, G; Mom, A; Pecorini, V; Pellerano, G; Perez, V | 1 |
Champion, RH | 1 |
Abel, EA; Charuworn, A; Farber, EM | 1 |
Bruckner, HW; Lokich, JJ; Stablein, DM | 1 |
Hill, GW; Roach, M | 1 |
Chintagumpala, M; Davino, N; Helman, L; Hicks, J; Johnson, M; Lau, CC; Man, TK; Meyer, W; Murray, J; Perlaky, L; Shen, J; Triche, T; Visvanathan, J; Wong, KK | 1 |
Antonelli, A; Carpi, A; Cervetti, G; Fallahi, P; Franzoni, F; Galetta, F; Petrini, M; Regoli, F; Santoro, G; Tocchini, L | 1 |
Bahrami, A; Davidoff, AM; Fernandez-Pineda, I; Green, JF; McGregor, LM; Sandoval, JA | 1 |
3 review(s) available for razoxane and methotrexate
Article | Year |
---|---|
Chemoprotectants for cancer chemotherapy.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Asparaginase; Cisplatin; Cyclophosphamide; Fluorouracil; Humans; Ifosfamide; Leucovorin; Mesna; Methotrexate; Neoplasms; Razoxane; Sulfhydryl Compounds; Uridine | 1991 |
Psoriasis and its treatment.
Topics: Administration, Topical; Adrenal Cortex Hormones; Anthralin; Humans; Hydroxyurea; Methotrexate; Middle Aged; Psoriasis; PUVA Therapy; Razoxane | 1981 |
Isolated subcutaneous metastasis of osteosarcoma 5 years after initial diagnosis.
Topics: Abdominal Wall; Antibodies, Monoclonal; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Calcinosis; Cisplatin; Combined Modality Therapy; Doxorubicin; Female; Humans; Ifosfamide; Lung Neoplasms; Methotrexate; Neoadjuvant Therapy; Organ Sparing Treatments; Osteosarcoma; Radiography; Razoxane; Receptor, IGF Type 1; Skin Neoplasms; Subcutaneous Tissue; Tibia; Time Factors; Young Adult | 2011 |
1 trial(s) available for razoxane and methotrexate
Article | Year |
---|---|
In vitro and in vivo study on the antioxidant activity of dexrazoxane.
Topics: Antineoplastic Combined Chemotherapy Protocols; Antioxidants; Bleomycin; Chromans; Cyclophosphamide; Cytarabine; Epirubicin; Etoposide; Female; Free Radical Scavengers; Glutathione; Humans; Lymphoma, Non-Hodgkin; Male; Methotrexate; Middle Aged; Prednisone; Razoxane; Time Factors; Uric Acid; Vincristine | 2010 |
12 other study(ies) available for razoxane and methotrexate
Article | Year |
---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Razoxane and methotrexate resistance.
Topics: Cell Line; Cell Survival; Drug Resistance; Humans; Lymphocytes; Methotrexate; Neoplasms; Piperazines; Razoxane | 1977 |
Comparative study of early effects of epipodophyllotoxin derivatives and other cytostatic agents on mastocytoma cultures.
Topics: Antineoplastic Agents; Bleomycin; Cell Division; Cell Line; Colchicine; Cytarabine; DNA, Neoplasm; Etoposide; Mast-Cell Sarcoma; Mechlorethamine; Mercaptopurine; Methotrexate; Mitosis; Neoplasm Proteins; Neoplasms, Experimental; Podophyllotoxin; Razoxane; RNA, Neoplasm; Teniposide; Vincristine; X-Rays | 1977 |
Augmentation of cytotoxic drug action and X-irradiation by antibodies.
Topics: Antibodies, Neoplasm; Antineoplastic Agents; Cell Division; Cell Line; Cell Membrane; Chlorambucil; Clone Cells; Lomustine; Methotrexate; Neoplasms, Experimental; Radiation Effects; Razoxane; Vinblastine | 1975 |
Efficacy of bimolane in the Malassezia ovalis model of psoriasis.
Topics: Administration, Cutaneous; Administration, Oral; Animals; Betamethasone Valerate; Disease Models, Animal; Female; Injections, Intravenous; Malassezia; Methotrexate; Psoriasis; Rabbits; Razoxane; Skin | 1991 |
Methotrexate in lieu of razoxane for incapacitating psoriasis.
Topics: Humans; Leukemia, Myeloid, Acute; Methotrexate; Piperazines; Psoriasis; Razoxane; Skin Neoplasms | 1984 |
Further experience in treating patients with hepatocellular carcinoma in Uganda.
Topics: Adolescent; Adult; Aged; alpha-Fetoproteins; Azacitidine; Carcinoma, Hepatocellular; Child; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Female; Hepatic Artery; Humans; Injections, Intravenous; Ligation; Liver Neoplasms; Male; Methotrexate; Middle Aged; Pigmentation Disorders; Razoxane; Uganda | 1980 |
Razoxane in the treatment of psoriatic patients resistant to or intolerant of PUVA, methotrexate and etretinate.
Topics: Adult; Aged; Drug Resistance; Etretinate; Female; Humans; Male; Methotrexate; Middle Aged; Piperazines; Psoriasis; PUVA Therapy; Razoxane | 1982 |
Recent advances in the treatment of psoriasis.
Topics: Anthralin; Coal Tar; Drug Therapy, Combination; Etretinate; Humans; Methotrexate; Psoriasis; PUVA Therapy; Razoxane; Tretinoin; Ultraviolet Therapy | 1983 |
Studies of Baker's antifol, methotrexate, and razoxane in advanced gastric cancer: A Gastrointestinal Tumor Study Group Report.
Topics: Adenocarcinoma; Antineoplastic Agents; Female; Gastrointestinal Neoplasms; Humans; Male; Methotrexate; Middle Aged; Myeloproliferative Disorders; Prognosis; Random Allocation; Razoxane; Triazines | 1982 |
Razoxane in the treatment of psoriasis.
Topics: Chemical and Drug Induced Liver Injury; Humans; Methotrexate; Piperazines; Psoriasis; Razoxane | 1980 |
Expression profiles of osteosarcoma that can predict response to chemotherapy.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Biopsy; Bone Neoplasms; Child; Cisplatin; Combined Modality Therapy; Doxorubicin; Drug Resistance, Neoplasm; Female; Gene Expression Profiling; Humans; Male; Methotrexate; Neoplasm Recurrence, Local; Nuclear Proteins; Osteosarcoma; Predictive Value of Tests; Prognosis; Razoxane; Reverse Transcriptase Polymerase Chain Reaction; Survival Rate; Twist-Related Protein 1 | 2005 |